在2003年至2019年期间,在德国癌症死亡率方面扩大了基于地区的社会经济不平等
Fabian Tetzlaff1, Enno Nowossadeck2, Lina Jansen3
1Division of Social Determinants of Health, Department of Epidemiology and Health Monitoring, Robert Koch Institute, Nordufer 20, 13302, Berlin, Germany. TetzlaffF@rki.de.
Scientific reports
|October 19, 2023
概括
德国贫困地区的癌症死亡率更高,这一差距正在扩大. 这项研究揭示了癌症结果中越来越多的社会经济不平等,特别是在男性中. 需要进一步的研究来解决这些差异.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 社会医学 社会医学
背景情况:
- 癌症死亡率在全国范围内有所下降,但由于数据有限,德国的社会经济差异仍未得到充分研究.
- 之前的研究缺乏全国性,个体级数据来评估癌症死亡率趋势中的社会经济不平等.
研究的目的:
- 通过基于地区的方法,调查德国癌症死亡率的社会经济不平等.
- 分析全国社会经济群体之间癌症死亡率差异的长期趋势.
- 确定有针对性癌症预防和控制战略的高需求地区.
主要方法:
- 将官方死亡原因数据 (2003-2019) 与德国地区级社会经济贫困指数联系起来.
- 基于区域社会经济贫困,计算了所有癌症和特定癌症的年龄标准化死亡率.
- 使用多层Poisson模型估计的绝对 (SII) 和相对 (RII) 不平等指数.
主要成果:
- 与最贫困地区相比,癌症死亡率在最贫困地区的癌症死亡率要高得多 (女性高50%,男性高80%).
- 在研究期间,癌症死亡率的社会经济差距扩大,因为死亡率下降在较不贫困地区更为.
- 肺癌 (女性) 和胰腺癌 (两性) 的死亡率增加,特别是在贫困地区.
结论:
- 这项研究提供了第一个全国性的证据,证明德国癌症死亡率的社会经济不平等正在增加.
- 基于区域的分析有效地突出了差异,并可以指导区域癌症控制工作.
- 有针对性的干预措施对于解决癌症结局中日益扩大的社会经济差距至关重要.
更多相关视频
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
222
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
01:20Comparing the Survival Analysis of Two or More Groups
201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
01:25Statistical Methods for Analyzing Epidemiological Data
385
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
385
01:24Kaplan-Meier Approach
154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K